* Prestige Consumer Healthcare Inc PBH.N reported a
quarterly
adjusted loss of $4.83 per share for the quarter ended in
March. The mean expectation of seven analysts for the quarter
was for earnings of $1.04 per share.
* Revenue rose 7.1% to $285.87 million from a year ago;
analysts
expected $279.00 million.
* Prestige Consumer Healthcare Inc's reported EPS for the
quarter
was a loss of $4.83.
* The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Prestige Consumer Healthcare Inc shares had fallen by 2.2%
this
quarter and lost 2.2% so far this year.
* The company reported a quarterly loss of $240.55 million.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $70.50
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
4 at 01:33 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 1.04 -4.83 Missed
Dec. 31 2022 1.01 1.04 Beat
Sep. 30 2022 1.00 1.02 Beat
Jun. 30 2022 1.04 1.09 Beat